Literature DB >> 14960499

Pain catastrophizing and neural responses to pain among persons with fibromyalgia.

R H Gracely1, M E Geisser, T Giesecke, M A B Grant, F Petzke, D A Williams, D J Clauw.   

Abstract

Pain catastrophizing, or characterizations of pain as awful, horrible and unbearable, is increasingly being recognized as an important factor in the experience of pain. The purpose of this investigation was to examine the association between catastrophizing, as measured by the Coping Strategies Questionnaire Catastrophizing Subscale, and brain responses to blunt pressure assessed by functional MRI among 29 subjects with fibromyalgia. Since catastrophizing has been suggested to augment pain perception through enhanced attention to painful stimuli, and heightened emotional responses to pain, we hypothesized that catastrophizing would be positively associated with activation in structures believed to be involved in these aspects of pain processing. As catastrophizing is also strongly associated with depression, the influence of depressive symptomatology was statistically removed. Residual scores of catastrophizing controlling for depressive symptomatology were significantly associated with increased activity in the ipsilateral claustrum (r = 0.51, P < 0.05), cerebellum (r = 0.43, P < 0.05), dorsolateral prefrontal cortex (r = 0.47, P < 0.05), and parietal cortex (r = 0.41, P < 0.05), and in the contralateral dorsal anterior cingulate gyrus (ACC; r = 0.43, P < 0.05), dorsolateral prefrontal cortex (r = 0.41, P < 0.05), medial frontal cortex (r = 0.40, P < 0.05) and lentiform nuclei (r = 0.40, P < 0.05). Analysis of subjects classified as high or low catastrophizers, based on a median split of residual catastrophizing scores, showed that both groups displayed significant increases in ipsilateral secondary somatosensory cortex (SII), although the magnitude of activation was twice as large among high catastrophizers. Both groups also had significant activations in contralateral insula, SII, primary somatosensory cortex (SI), inferior parietal lobule and thalamus. High catastrophizers displayed unique activation in the contralateral anterior ACC, and the contralateral and ipsilateral lentiform. Both groups also displayed significant ipsilateral activation in SI, anterior and posterior cerebellum, posterior cingulate gyrus, and superior and inferior frontal gyrus. These findings suggest that pain catastrophizing, independent of the influence of depression, is significantly associated with increased activity in brain areas related to anticipation of pain (medial frontal cortex, cerebellum), attention to pain (dorsal ACC, dorsolateral prefrontal cortex), emotional aspects of pain (claustrum, closely connected to amygdala) and motor control. These results support the hypothesis that catastrophizing influences pain perception through altering attention and anticipation, and heightening emotional responses to pain. Activation associated with catastrophizing in motor areas of the brain may reflect expressive responses to pain that are associated with greater pain catastrophizing.

Entities:  

Mesh:

Year:  2004        PMID: 14960499     DOI: 10.1093/brain/awh098

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  225 in total

1.  Dysfunctional pain modulation in somatoform pain disorder patients.

Authors:  Stefanie Klug; Klug Stefanie; Peter Anderer; Anderer Peter; Gerda Saletu-Zyhlarz; Saletu-Zyhlarz Gerda; Marion Freidl; Freidl Marion; Bernd Saletu; Saletu Bernd; Wolfgang Prause; Prause Wolfgang; Martin Aigner; Aigner Martin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-06       Impact factor: 5.270

2.  Impaired brachial artery endothelial function in young healthy women following an acute painful stimulus.

Authors:  T J King; H Lemke; A D Green; D A Tripp; V J Poitras; B J Gurd; K E Pyke
Journal:  Eur J Appl Physiol       Date:  2015-03-01       Impact factor: 3.078

3.  Patient kinesiophobia affects both recovery time and final outcome after total knee arthroplasty.

Authors:  G Filardo; A Roffi; G Merli; T Marcacci; F Berti Ceroni; D Raboni; B Bortolotti; L De Pasqual; M Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-19       Impact factor: 4.342

Review 4.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

5.  Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing.

Authors:  Christopher D King; Burel Goodin; Lindsay L Kindler; Robert M Caudle; Robert R Edwards; Nikolaus Gravenstein; Joseph L Riley; Roger B Fillingim
Journal:  J Behav Med       Date:  2012-04-26

6.  The Role of Heart Rate Variability in Mindfulness-Based Pain Relief.

Authors:  Adrienne L Adler-Neal; Christian E Waugh; Eric L Garland; Hossam A Shaltout; Debra I Diz; Fadel Zeidan
Journal:  J Pain       Date:  2019-08-01       Impact factor: 5.820

Review 7.  Pain and depression: an integrative review of neurobiological and psychological factors.

Authors:  Jenna Goesling; Daniel J Clauw; Afton L Hassett
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 8.  Pain and analgesia: the value of salience circuits.

Authors:  David Borsook; Robert Edwards; Igor Elman; Lino Becerra; Jon Levine
Journal:  Prog Neurobiol       Date:  2013-03-07       Impact factor: 11.685

9.  Cold intolerance after brachial plexus nerve injury.

Authors:  Christine B Novak; Dimitri J Anastakis; Dorcas E Beaton; Susan E Mackinnon; Joel Katz
Journal:  Hand (N Y)       Date:  2011-11-12

10.  Alterations in Connectivity on Functional Magnetic Resonance Imaging with Provocation of Lower Urinary Tract Symptoms: A MAPP Research Network Feasibility Study of Urological Chronic Pelvic Pain Syndromes.

Authors:  Natalia M Kleinhans; Claire C Yang; Eric D Strachan; Dedra S Buchwald; Kenneth R Maravilla
Journal:  J Urol       Date:  2015-10-22       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.